Shareholders in Aim-listed firms usually dread fundraising, says David Thornton. But this time, shareholders in Optimal Payments have cause to celebrate.
Articles written by David Thornton
Isas have been hugely successful in encouraging wealth-building habits among the British public. But George Osborne’s latest tinkering threatens to undermine that, says David Thornton.
Investing in small growth-stocks is exciting, but it also pays to look for quality, says David Thornton. That means dividends.
It’s easy to knock Aim, says David Thornton. But it plays a key role in developing the small-company sector of Britain’s economy.
Many patients are sent abroad at great expense to the NHS, says David Thornton. But thanks to this Aim-listed company, that could be about to change.
Becoming a government supplier can make a huge difference to a firm’s share price, says David Thornton. Here, he looks at one Aim-listed stock that’s hit the big time.
A new record high for the FTSE 100 makes a nice headline. But if you want really sensational returns, stick with smaller companies, says David Thornton.
Equities – penny shares in particular – are the best way of generating a good long-term return, says David Thornton. But it requires the right attitude and a sensible strategy.
The bizarre goings-on at Chinese sportswear manufacturer Naibu are a warning to investors, says David Thornton. Do your homework before handing over any money.
AstraZeneca’s interest in a small biotech firm is a reminder of why tiny drug companies are so important, says David Thornton.